WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Stock Ownership - Who owns Immuneering?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immuneering Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin J. ZeskindPRESIDENT AND CEO2026-06-232,400$4.56
$10.95kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2026-06-156,035$4.15
$25.05kBuy
Leah R. NeufeldCHIEF PEOPLE OFFICER2026-03-133,628$4.29
$15.58kBuy
Harold Eugene BrakewoodChief Business Officer2026-01-165,250$4.76
$24.99kBuy
Thomas J. SchallDirector2026-01-1521,645$4.67
$101.04kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2026-01-152,298$4.57
$10.50kBuy
Leah R. NeufeldCHIEF PEOPLE OFFICER2026-01-132,626$4.15
$10.91kBuy
Peter FeinbergDirector2026-01-1220,000$4.35
$86.90kBuy
Peter FeinbergDirector2025-10-037,500$6.67
$50.03kBuy
Mallory MoralesChief Accounting Officer2025-10-01300$6.39
$1.92kBuy

1 of 2

IMRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMRX insiders and whales buy or sell their stock.

IMRX Shareholders

What type of owners hold Immuneering Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP10.97%7,099,637$31.81MInsider
Benjamin J. Zeskind5.80%3,755,106$16.82MInsider
Peter Feinberg2.32%1,500,798$6.72MInsider
Robert J. Carpenter1.78%1,148,839$5.15MInsider
Brett Matthew Hall0.59%382,531$1.71MInsider
Andrew Gengos0.35%225,000$1.01MInsider
Thomas J. Schall0.12%74,530$333.89kInsider
Ann E. Berman0.10%67,465$302.24kInsider
Leah R. Neufeld0.05%29,598$132.60kInsider
Mallory Morales0.04%27,533$123.35kInsider

1 of 3

IMRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMRX0.05%22.20%Net BuyingNet Buying
UPB0.09%33.20%Net SellingNet Selling
FULC0.10%55.90%Net SellingNet Buying
GLSI0.01%89.01%Net BuyingNet Buying
PYXS0.04%40.13%Net BuyingNet Buying
View Top Biotech Stocks

Immuneering Stock Ownership FAQ

Who owns Immuneering?

Immuneering (NASDAQ: IMRX) is owned by 0.05% institutional shareholders, 22.20% Immuneering insiders, and 77.75% retail investors. Cormorant Asset Management LP is the largest individual Immuneering shareholder, owning 7.10M shares representing 10.97% of the company. Cormorant Asset Management LP's Immuneering shares are currently valued at $31.81M.

If you're new to stock investing, here's how to buy Immuneering stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.